701. Efficacy and safety of COMP360 psilocybin therapy in anorexia nervosa: a proof-of-concept study
International Journal of Neuropsychopharmacology September 9, 2026 G Goodwin
Abstract Background There are no approved medications for treating anorexia nervosa (AN) despite having the highest mortality rate of all psychiatric conditions. Talk therapies have limited efficacy, with relapse rates as high as 52% and poor long-term outcomes. Aims & Objectives This study evaluated the effects and safety of COMP360 psilocybin, a novel treatment, in individuals with anorexia...